Gefitinib, a pharmacological inhibitor of EGFR inhibits growth and invasion of urothelial cell lines in which erbB1 is constitutively activated

被引：0
|
作者：
Nicole, G
Vordos, D
Daher, A
Maillé, P
Bakkar, A
Pages, C
Jouault, H
Abbou, CC
de Medina, SGD
Chopin, DK
机构：
来源：
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)34818-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
578
引用
收藏
页码：158 / 158
页数：1
相关论文
共 46 条
  • [41] Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines
    Shintani, S
    Li, CN
    Mihara, M
    Yano, J
    Terakado, N
    Nakashiro, K
    Hamakawa, H
    ORAL ONCOLOGY, 2004, 40 (01) : 43 - 51
  • [42] Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1/p21 signaling
    Yu, Xiaojun
    Ye, Zhenghui
    Hou, Liujin
    Zhang, Xinghua
    Liu, Zimei
    Wu, Ruolin
    Huang, Fan
    Wang, Guobin
    Geng, Xiaoping
    Zhao, Hongchuan
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2022, 16 (02) : 179 - 190
  • [43] Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1/p21 signaling
    Xiaojun Yu
    Zhenghui Ye
    Liujin Hou
    Xinghua Zhang
    Zimei Liu
    Ruolin Wu
    Fan Huang
    Guobin Wang
    Xiaoping Geng
    Hongchuan Zhao
    Journal of Cell Communication and Signaling, 2022, 16 : 179 - 190
  • [44] Peroxisome proliferators-activated receptors (PPARs) attenuate IGF-1-mediated growth responses in very aggressive mouse medulloblastorna cell line, which express JCV T-antigen, and in several human medulloblastoma cell lines
    Chintapalli, Janaki
    Grabacka, Maja
    Reiss, Krzysztof
    JOURNAL OF NEUROVIROLOGY, 2006, 12 : 14 - 14
  • [45] BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth
    Yasui, Hiroshi
    Hideshima, Teru
    Ikeda, Hiroshi
    Jin, Janice
    Ocio, Enrique M.
    Kiziltepe, Tanyel
    Okawa, Yutaka
    Vallet, Sonia
    Podar, Klaus
    Ishitsuka, Kenji
    Richardson, Paul G.
    Pargellis, Chris
    Moss, Neil
    Raje, Noopur
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (03) : 414 - 423
  • [46] Predictive factors for T790M mutation in plasma in patients after progression to 1st line tyrosine-kinase inhibitor (TKI) with or without subsequent lines of TKI or chemotherapy for metastatic epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
    Lau, K-S.
    So, T-H.
    Choy, T-S.
    Leung, D. K.
    Lam, K-O.
    Ho, P. Y. P.
    Chan, W-L.
    Wong, L-S.
    Chan, S-Y.
    Chan, F-T.
    Tse, R. P.
    Choi, C-W.
    Lam, T-C.
    Kwong, D. W.
    Lee, A.
    Leung, T-W.
    Lee, V. H.
    ANNALS OF ONCOLOGY, 2016, 27
12345